Streptococcus pneumoniae serotype-specific immune response

The "Streptococcus pneumoniae serotype-specific immune response" refers to host adaptive immunity targeting serotype-defining capsular polysaccharides and protein antigens of *Streptococcus pneumoniae*, a major human pathogen[1][3][5]. Each pneumococcal serotype possesses a distinct capsular polysaccharide that dictates immunological recognition and vaccine response[3][6]. Vaccine-induced or natural infection-induced immunity involves serotype-specific antibody production (predominantly IgG), complement activation, and Th17-mediated cellular immune responses, all contributing to protection against colonization and invasive disease. However, coverage is serotype dependent and not all pneumococcal strains are equally targeted[5]. This is not a single protein, receptor, or molecular target, but a collective immune response to diverse serotype antigens.

Other names

Pneumococcal serotype immune responseSerotype-specific pneumococcal immunity

Vaccines elicit serotype-specific antibodies that target polysaccharide capsule antigens, promoting opsonization, complement activation, and enhanced phagocytosis